Content-Length: 316874 | pFad | https://doi.org/10.1038/ijo.2017.233

ma=86400 Long-term metabolic risk for the metabolically healthy overweight/obese phenotype | International Journal of Obesity
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Epidemiology and Population Health

Long-term metabolic risk for the metabolically healthy overweight/obese phenotype

International Journal of Obesity volume 42, pages 302–309 (2018)Cite this article

Subjects

Abstract

Background/Objectives:

The clinical relevance of the metabolically healthy overweight/obese (MHO) phenotype is controversial and the relationships between weight change and the development of cardiometabolic risk factors is unknown. Therefore, we aim to: (1) Assess the long-term risk of developing one or more components of the metabolic syndrome in MHO adults compared with metabolically healthy normal weight (MHNW); (2) Evaluate risk of a composite of death, cardiovascular disease (CVD), and risk of developing type 2 diabetes between adults defined according to baseline body mass index and metabolic health.

Subjects/Methods:

Retrospective cohort study of adults 18–65 years of age seen at our institution between 1998 and 2000 who lived in Olmsted County. Metabolically healthy was defined as the absence of all components of the metabolic syndrome (except for waist circumference). Main outcome was the development of metabolic risk factors. The secondary outcome was a composite of mortality, CVD and heart failure.

Results:

Of the 18 070 individuals with complete data at baseline, 1805 (10%) were MHO (mean age 38±11 years) and 3047 were MHNW (mean age 35±11 years). After a median follow-up of 15 years, interquartile range 10–17, 80% of MHO vs 68% of MHNW developed at least one cardiometabolic risk factor (P<0.001). In multivariate analysis, MHO individuals who gained ⩾10% of their body weight were more likely to have developed metabolic complications compared to MHO individuals that did not gain weight (P=0.001 for 10–15%, P<0.001 for >15% weight gain). The risk for the secondary composite end point was similar between MHO and MHNW, number of events 218/1805 vs 217/3048 for MHO and MHNW, respectively, (hazard ratio: 1.16, 95% confidence interval: 0.96–1.40).

Conclusions:

MHO are more likely to develop metabolic complications than MHNW, especially if they gain weight.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzi AG, Donato KA et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129: S102–S138.

    Article  Google Scholar 

  2. Schroder H, Ramos R, Baena-Diez JM, Mendez MA, Canal DJ, Fito M et al. Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population. Eur J Nutr 2014; 53: 1345–1353.

    Article  Google Scholar 

  3. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013; 36: 2388–2394.

    Article  Google Scholar 

  4. Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 2015; 36: 551–559.

    Article  Google Scholar 

  5. Senechal M, Wicklow B, Wittmeier K, Hay J, MacIntosh AC, Eskicioglu P et al. Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth. Pediatrics 2013; 132: e85–e92.

    Article  Google Scholar 

  6. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P . Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010; 64: 1043–1051.

    Article  CAS  Google Scholar 

  7. Kramer CK, Zinman B, Retnakaran R . Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 2013; 159: 758–769.

    Article  Google Scholar 

  8. Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I . Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway. J Am Coll Cardiol 2014; 63: 1071–1078.

    Article  Google Scholar 

  9. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP . Incident cardiovascular disease events in metabolically benign obese individuals. Obesity 2012; 20: 651–659.

    Article  Google Scholar 

  10. Zheng R, Zhou D, Zhu Y . The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health 2016; 70: 1024–1031.

    Article  Google Scholar 

  11. Soriguer F, Gutierrez-Repiso C, Rubio-Martin E, Garcia-Fuentes E, Almaraz MC, Colomo N et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 2013; 98: 2318–2325.

    Article  CAS  Google Scholar 

  12. Al Suwaidi J . Is there an increased cardiovascular risk in metabolically healthy obese individuals? Lessons from the HUNT (Nord-Trondelag Health) study. Glob Cardiol Sci Pract 2014; 2014: 44–47.

    Article  Google Scholar 

  13. Hamer M, Stamatakis E . Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482–2488.

    Article  CAS  Google Scholar 

  14. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894, i-xii 1–253, http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/.

  15. Alberti KG, Zimmet P, Shaw J . The metabolic syndrome—a new worldwide definition. Lancet 2005; 366: 1059–1062.

    Article  Google Scholar 

  16. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF . Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005; 43: 480–485.

    Article  Google Scholar 

  17. Andrade SE, Harrold LR, Tjia J, Cutrona SL, Saczynski JS, Dodd KS et al. A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf 2012; 21 (Suppl 1): 100–128.

    Article  Google Scholar 

  18. Mell MW, Pettinger M, Proulx-Burns L, Heckbert SR, Allison MA, Criqui MH et al. Evaluation of medicare claims data to ascertain peripheral vascular events in the Women's Health Initiative. J Vasc Surg 2014; 60: 98–105.

    Article  Google Scholar 

  19. R Development Core Team. (2008). R Foundation for Statistical Computing. Vienna, Austria. http://www.R-project.org.

  20. Tomiyama AJ, Hunger JM, Nguyen-Cuu J, Wells C . Misclassification of cardiometabolic health when using body mass index categories in NHANES 2005-2012. Int J Obes 2016; 40: 883–886.

    Article  CAS  Google Scholar 

  21. Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD, Kivimaki M . The natural course of healthy obesity over 20 years. J Am Coll Cardiol 2015; 65: 101–102.

    Article  Google Scholar 

  22. Wei GS, Coady SA, Reis JP, Carnethon MR, Coresh J, D'Agostino RB Sr et al. Duration and degree of weight gain and incident diabetes in younger versus middle-aged Black and White Adults: ARIC, CARDIA, and the Framingham Heart Study. Diabetes Care 2015; 38: 2042–2049.

    Article  Google Scholar 

  23. Franklin SS, Pio JR, Wong ND, Larson MG, Leip EP, Vasan RS et al. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation 2005; 111: 1121–1127.

    Article  Google Scholar 

  24. Cui Z, Truesdale KP, Bradshaw PT, Cai J, Stevens J . Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: the atherosclerosis risk in communities study. Int J Obes 2015; 39: 1203–1208.

    Article  CAS  Google Scholar 

  25. Lewis CE, Jacobs DR Jr, McCreath H, Kiefe CI, Schreiner PJ, Smith DE et al. Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 2000; 151: 1172–1181.

    Article  CAS  Google Scholar 

  26. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM . Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168–1173.

    Article  CAS  Google Scholar 

  27. Ebbert JO, Jensen MD . Fat depots, free fatty acids, and dyslipidemia. Nutrients 2013; 5: 498–508.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr Arlene Calvo and Morgan Hess-Holtz from the University of South Florida Health Panama for their help with cumulative incidence analysis. This manuscript was supported by CTSA Grant Number TL1 TR000137 from the National Center for Advancing Translational Science (NCATS), grant DK050456 from the US Public Health Service and the Mayo Foundation.

Disclaimer

Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

  1. Division of Endocrinology, Department of Internal Medicine, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA

    AE Espinosa De Ycaza, D Donegan & M D Jensen

  2. Facultad de Medicina, Universidad de Panamá, Panama City, Republic of Panama

    AE Espinosa De Ycaza & D Donegan

  3. Department of Internal Medicine, Endocrine Research Unit, Mayo Clinic, Rochester, MN, USA

    M D Jensen

Authors
  1. AE Espinosa De Ycaza
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. D Donegan
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. M D Jensen
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to M D Jensen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Espinosa De Ycaza, A., Donegan, D. & Jensen, M. Long-term metabolic risk for the metabolically healthy overweight/obese phenotype. Int J Obes 42, 302–309 (2018). https://doi.org/10.1038/ijo.2017.233

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2017.233

Search

Advanced search

Quick links









 ApplySandwichStrip

pFad - (p)hone/(F)rame/(a)nonymizer/(d)eclutterfier!      Saves Data!


--- a PPN by Garber Painting Akron. With Image Size Reduction included!

Fetched URL: https://doi.org/10.1038/ijo.2017.233

Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy